Sumitomo Mitsui Trust Group, Inc.
Position in CRSP — CRISPR Therapeutics AG
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in CRSP
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$93,848,832
+$5,659,999 QoQ
Shares Held
1,720,734
-7.2% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#12
of 521 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,307,870,799 across 36 Biotechnology names. CRSP ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
611,907 | $303,952,564 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
282,199 | $175,962,364 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,067,324 | $146,056,440 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
325,379 | $97,948,840 | |
| 6 | CRSP |
CRISPR Therapeutics AG
This page
|
1,720,734 | $93,848,832 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,187,943 | $66,607,964 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
306,300 | $57,363,864 |
All Filings in CRSP
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,848,832 | 1,720,734 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $88,188,833 | 1,853,875 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $102,683,340 | 1,958,111 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $140,227,776 | 2,163,675 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $117,457,720 | 2,414,838 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $86,432,422 | 2,539,889 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $108,069,807 | 2,745,676 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $139,438,237 | 2,968,034 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $170,213,271 | 3,151,514 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $222,800,385 | 3,268,785 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $210,947,101 | 3,369,762 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $157,297,683 | 3,465,470 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $198,362,661 | 3,533,357 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $179,706,931 | 3,973,180 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $162,863,249 | 4,006,476 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $278,569,797 | 4,262,736 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $278,575,635 | 4,584,098 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $289,981,519 | 4,619,747 | Shares | Defined | 2022-04-27 | |
| No filing history on record for this holder in this stock. | ||||||